A newly released large-scale study out of Florida, co-authored by Dr. Joe Ladapo, the state’s Surgeon General, is raising serious questions about the safety of mRNA COVID-19 vaccines—particularly Pfizer’s version, Outkick.com reports. The research analyzed data from more than 9 million Florida residents and looked at a critical outcome: deaths from all causes, not just those related to COVID-19. The results are unsettling.
The study focused on both the Pfizer and Moderna vaccines, aiming to go beyond COVID-specific outcomes to assess broader health impacts. The researchers set out to address a gap left by initial trials, which, they argue, were not robust enough to identify mortality differences between vaccines.
“Pooled data from the initial, pivotal randomized trials evaluating BNT162b2 (Pfizer BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines were underpowered to detect differences in overall mortality compared to placebo,” the study says. “Moreover, no trial was conducted to compare the relative effects of different vaccines. While findings from these trials suggested that both vaccines reduced deaths due to COVID-19, pooled all-cause deaths were not reduced. Cardiac deaths were more frequent, with a relative but statistically insignificant increase of 50% and 40% compared to the placebo groups among BNT162b2 and mRNA-1273 vaccine recipients, respectively.”
The authors noted a key flaw in many existing studies: the “healthy vaccinee bias.” Healthier individuals are more likely to get vaccinated, which can skew results to make vaccines appear more effective than they may actually be when measured across the general population.
“Nonspecific vaccine effects can be directly assessed in observational studies by evaluating a vaccine’s impact on all-cause mortality and other outcomes,” they write. “However, the results of these studies are prone to multiple biases, including healthy vaccinee bias, i.e., observed and unobserved characteristics that have a confounding effect on the decision to vaccinate and an outcome. As a result, they often have relatively low reliability. Moreover, healthy vaccinee bias, likely the result of substantial unobserved differences between vaccinated and unvaccinated individuals, were demonstrated in observational studies of COVID-19 vaccination, even in studies using matching or risk adjustment.”
To minimize that bias, the researchers employed a matched cohort approach, comparing individuals who received different mRNA vaccines rather than comparing vaccinated people to the unvaccinated.
“Nonspecific vaccine effects may also be indirectly assessed by evaluating health outcomes among patients who receive different vaccines for the same indication. This type of comparison is less likely to be vulnerable to healthy vaccinee bias and has already been demonstrated for COVID-19 vaccines.”
Using this methodology, the researchers examined all-cause mortality among vaccine recipients with closely matched demographics and health profiles. Their findings contradict much of the mainstream narrative about the vaccines’ safety.
The study looked at 9.1 million adults in Florida not residing in institutions like nursing homes. Among them, over 5.3 million received Pfizer’s vaccine and more than 3.8 million got Moderna’s. After applying a rigorous matching system based on seven criteria, the researchers matched over 1.4 million people one-to-one for a direct comparison.
The data revealed a significantly greater death rate among Pfizer recipients. Between December 18, 2020, and August 31, 2021, those vaccinated with Pfizer’s shot had an all-cause mortality rate of 847.2 deaths per 100,000, versus 617.9 per 100,000 for Moderna. The disparity extended to cardiovascular deaths, with Pfizer showing 248.7 per 100,000 compared to 162.4 per 100,000 for Moderna.
The trend held across other categories as well. When it came to COVID-related deaths, Pfizer vaccine recipients had a rate of 55.5 per 100,000 compared to 29.5 per 100,000 for Moderna. For non-COVID deaths, the numbers were 791.6 for Pfizer and 588.4 for Moderna.
Summing up the findings, the authors stated that individuals who received the Pfizer vaccine had a “significantly higher risk of 12-month all-cause, cardiovascular, COVID-19, and non-COVID-19 mortality compared to matched mRNA-1273 recipients.
“These findings are suggestive of differential non-specific effects of the BNT162b2 and mRNA-1273 COVID-19 vaccines, and potential concerning adverse effects on all-cause and cardiovascular mortality. They underscore the need to evaluate vaccines using clinical endpoints that extend beyond their targeted diseases.”
In short, the study introduces the possibility that Pfizer’s vaccine may have contributed to a higher likelihood of dying from a range of causes—including cardiovascular issues—compared to Moderna’s shot. The authors suggest it’s time for a broader reevaluation of how vaccines are assessed and approved, emphasizing the need to examine real-world outcomes that go far beyond the original scope of disease prevention.
{Matzav.com}